Lumos Diagnostics Holdings Health Care

$0.011 0.001 (10.00%)

High $0.01	Low $0.01	Trades 62	Turnover $15,077	Volume 1,373,136
30 June 2023 at 4:10pm

Register to track LDX and receive email alerts.

Market Cap (19-Sep) $106,245,528 (853rd)	Close (30-Jun) $0.011 0 (0%)	Volume (30-Jun) 1,373,136	Shortsold (27-Apr) 23,548 (0.00%) (616th)
52w High $0.330	52w Low $0.026	P/E -	EPS -0.02

	Subject
	LDX LDX Ann: Change of General Meeting format to Virtual Meeting
	1 (current) 2 3
	LDX LDX Ann: Change of Director's Interest Notice - SL
	LDX LDX Ann: Change of Director's Interest Notice - BLG
	LDX LDX Ann: Change of Director's Interest Notice - CR
	LDX LDX Ann: Cessation of Listed Options
	LDX LDX Ann: Application for quotation of securities - LDX
	LDX LDX Ann: Section 708A Cleansing Statement
	LDX LDX Ann: New Constitution
	LDX LDX Ann: Notification regarding unquoted securities - LDX
	LDX LDX Ann: Results of Annual General Meeting
	LDX LDX Ann: AGM Chair Address & Presentation
	LDX LDX Ann: Appendix 2A
	LDX LDX Ann: Lumos Secures Two Service Agreements With Hologic
	LDX LDX Ann: Notice of General Meeting/Proxy Form
	LDX LDX Ann: LDX signs agreement to raise $8m & announces General Meeting
	LDX LDX Ann: Notice of Expiry of Listed Options
	LDX LDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LDX LDX Ann: Postponement of Annual General Meeting to 30 November 2022
	LDX LDX Ann: Publication of Data from DISRUPT Clinical Trial in JAMA
	LDX LDX Ann: Notification of cessation of securities - LDX
	LDX LDX Ann: Lumos Completes Closure of Sarasota Facility
	LDX LDX Ann: Outcome of Appeal to FDA for FebriDx
	LDX LDX Ann: Notification regarding unquoted securities - LDX
	LDX LDX Ann: Proposed issue of securities - LDX
	LDX LDX Ann: Notice of Annual General Meeting/Proxy Form
	LDX LDX Ann: Notification regarding unquoted securities - LDX
	LDX LDX Ann: Change in substantial holding
	LDX LDX Ann: Notification regarding unquoted securities - LDX
	LDX LDX Ann: Appendix 4G and Corporate Governance Statement
	LDX LDX Ann: FY22 Full Year Results Investor Presentation
	LDX LDX Ann: FY22 Full Year Results Media Release
	LDX LDX Ann: FY22 Annual Report
	LDX LDX Ann: FY22 Appendix 4E
	LDX LDX Ann: Release of Shares from Escrow
	LDX LDX Ann: Lumos Pilot Manufacturing to Commence in Carlsbad
	LDX LDX Ann: Notice of Initial Substantial Holder from RYD
	LDX LDX Ann: Change in substantial holding
	LDX LDX Ann: Lumos Withdraws from Local Manufacturing Proposal
	LDX LDX Ann: Lumos Files Appeal To The FDA For FebriDx
	LDX LDX Ann: Lumos To Close Sarasota Facility
	LDX LDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	LDX LDX Ann: Notification of cessation of securities - LDX
	LDX LDX Ann: Reinstatement to Official Quotation
	LDX LDX Ann: FDA Decision for FebriDx
	LDX LDX Ann: Voluntary Suspension
	LDX LDX Ann: Trading Halt
	LDX LDX Ann: Change in substantial holding
	LDX LDX Ann: Change in substantial holding
	LDX LDX Ann: Change in substantial holding
	LDX LDX Ann: Security Class Reinstatement of Quotation LDXO

Register to track LDX and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.17	1,488,583	+0.01 (3.03%)
12-Sep	$0.17	10,519,273	+0.03 (17.86%)
11-Sep	$0.14	2,052,153	+0.01 (7.69%)
05-Sep	$0.13	2,600,487	+0.01 (8.33%)
04-Sep	$0.12	3,317,316	-0.01 (4.00%)
03-Sep	$0.13	6,478,141	0.00 (0.00%)
29-Aug	$0.13	4,480,169	-0.01 (7.41%)
28-Aug	$0.14	8,679,388	+0.04 (43.62%)
22-Aug	$0.09	2,912,119	0.00 (0.00%)
21-Aug	$0.09	9,155,483	-0.02 (14.55%)
15-Aug	$0.11	3,112,923	+0.01 (4.76%)
14-Aug	$0.11	7,527,259	+0.01 (10.53%)
07-Aug	$0.10	10,783,327	+0.02 (30.14%)
31-Jul	$0.07	5,414,052	0.00 (0.00%)
30-Jul	$0.07	11,974,595	+0.01 (8.96%)
9 up, 3 down, and 3 flat days